Publications list for Professor Glenn Salkeld

2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008


  • Robertson, J., Doran, E., Henry, D., Salkeld, G. (2014), Prescription medicines: decision-making preferences of patients who receive different levels of public subsidy. Health Expectations. 17(1), 15-26. [Abstract]


  • Yin, J., Salkeld, G., Lambert, S., Dierig, A., Heron, L., Leask, J., Yui Kwan Chow, M., Booy, R. (2013), Estimates and determinants of economic impacts from influenza-like illnesses caused by respiratory viruses in Australian children attending childcare: a cohort study. Influenza and Other Respiratory Viruses. 7(6), 1103-1112. [Abstract]
  • Yin, J., Heron, L., Salkeld, G., Rashid, H., Booy, R. (2013), Oseltamivir use in adolescents and adults: clinical and economic considerations. Infectious Disorders Drug Targets. 13(1), 53-58. [Abstract]
  • Rychetnik, L., Carter, S., Abelson, J., Thornton, H., Barratt, A., Entwistle, V., Mackenzie, G., Salkeld, G., Glasziou, P. (2013), Enhancing citizen engagement in cancer screening through deliberative democracy. Journal of the National Cancer Institute. 105(6), 380-386. [Abstract]
  • Weber, M., Cunich, M., Smith, D., Salkeld, G., Sitas, F., O'Connell, D. (2013), Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study. BMC Public Health. 13, 429. [Abstract]


  • Flitcroft, K., Irwig, L., Carter, S., Salkeld, G., Gillespie, J. (2012), Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option. BMC Gastroenterology. 12(1), 183. [Abstract]
  • Howard, K., Salkeld, G., Mann, G., Patel, M., Cunich, M., Pignone, M. (2012), The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study. BMJ Open. 2(1), e000587. [Abstract]
  • Wales, K., Clemson, L., Lannin, N., Cameron, I., Salked, G., Gitlin, L., Rubenstein, L., Barras, S., Mackenzie, L., Davies, C. (2012), Occupational therapy discharge planning for older adults: A protocol for a randomised trial and economic evaluation. BMC Geriatrics. 12, 34. [Abstract]
  • Yin, J., Salkeld, G., Heron, L., Booy, R. (2012), How to better inform the decision making about universal influenza vaccination in children. Journal of Pediatric Infectious Diseases. 7(2), 69-73.
  • Wong, G., Howard, K., Chapman, J., Pollock, C., Chadban, S., Salkeld, G., Tong, A., Williams, N., Webster, A., Craig, J. (2012), How do people with chronic kidney disease value cancer-related quality of life?. Nephrology. 17(1), 32-41. [Abstract]


  • Howard, K., Salkeld, G., Pignone, M., Hewett, P., Cheung, P., Olsen, J., Clapton, W., Roberts-Thomson, I. (2011), Preferences for CT Colonography and Colonoscopy as Diagnostic Tests for Colorectal Cancer: A Discrete Choice Experiment. Value in Health. 14(8), 1146-1152. [Abstract]
  • Yin, J., Wang, H., Skinner, S., Salkeld, G., Booy, R. (2011), Assessing seasonal vaccine-related cross-protection from 2009 pandemic H1N1 influenza through teacher absenteeism. Australian and New Zealand Journal of Public Health. , 393-394. [Abstract]
  • Flitcroft, K., Gillespie, J., Salkeld, G., Carter, S., Trevena, L. (2011), Getting evidence into policy: The need for deliberative strategies?. Social science & medicine. 72(7), 1039-0146. [Abstract]
  • Pignone, M., Flitcroft, K., Howard, K., Trevena, L., Salkeld, G., St John, D. (2011), Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. The Medical Journal of Australia. 194(4), 180-185. [Abstract]
  • Doran, E., Robertson, J., Salkeld, G. (2011), Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability. Australian Health Review. 35(1), 37-44. [Abstract]
  • Flitcroft, K., Gillespie, J., Carter, S., Trevena, L., Salkeld, G. (2011), When good evidence is not enough: the role of context in bowel cancer screening policy in New Zealand. Evidence & Policy: A Journal of Research, Debate and Practice. 7(3), 307-326.
  • Cunich, M., Salkeld, G., Dowie, J., Henderson, J., Bayram, C., Britt, H., Howard, K. (2011), Integrating evidence and individual preferences using a web-based multi-criteria decision analytic tool: an application to prostate cancer screening. The Patient. 4(3), 153-162. [Abstract]
  • Flitcroft, K., St John, D., Howard, K., Carter, S., Pignone, M., Salkeld, G., Trevena, L. (2011), A comparative case study of bowel cancer screening in the UK and Australia: evidence lost in translation?. Journal of Medical Screening. 18(4), 193-203. [Abstract]


  • Flitcroft, K., Salkeld, G., Gillespie, J., Trevena, L., Irwig, L. (2010), Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice?. Medical Journal of Australia. 193(1), 37-42. [Abstract]
  • Chim, L., Kelly, P., Salkeld, G., Stockler, M. (2010), Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?. PharmacoEconomics. 28(6), 463-75. [Abstract]
  • Howard, K., White, S., Salkeld, G., McDonald, S., Craig, J., Chadban, S., Cass, A. (2010), Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis. Value in Health. 13(2), 196-208. [Abstract]


  • Masya, L., Young, J., Solomon, M., Harrison, J., Dennis, R., Salkeld, G. (2009), Preferences for outcomes of treatment for rectal cancer: patient and clinician utilities and their application in an interactive computer-based decision aid. Diseases of the Colon and Rectum. 52(12), 1994-2002. [Abstract]
  • Harrison, J., Masya, L., Butow, P., Solomon, M., Young, J., Salkeld, G., Whelan, T. (2009), Implementing patient decision support tools: moving beyond academia?. Patient education and counseling. 76(1), 120-125. [Abstract]
  • Howard, K., Salkeld, G., White, S., McDonald, S., Chadban, S., Craig, J., Cass, A. (2009), The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology. 14(1), 123-132. [Abstract]
  • Howard, K., Salkeld, G. (2009), Does Attribute Framing in Discrete Choice Experiments Influence Willingness to Pay? Results from a Discrete Choice Experiment in Screening for Colorectal Cancer. Value in Health. 12(2), 354-363. [Abstract]


  • Mackenzie, R., Chapman, S., Salkeld, G., Holding, S. (2008), Media influence on Herceptin subsidization in Australia: application of the rule of rescue?. Journal of the Royal Society of Medicine. 101(6), 305-312. [Abstract]
  • Young, J., Solomon, M., Harrison, J., Salkeld, G., Butow, P. (2008), Measuring patient preference and surgeon choice. Surgery. 143(5), 582-588. [Abstract]
  • Howard, K., Salkeld, G., McCaffery, K., Irwig, L. (2008), HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?. Health Economics. 17(5), 593-605. [Abstract]
  • Harrison, J., Solomon, M., Young, J., Meagher, A., Butow, P., Salkeld, G., Hruby, G., Clarke, S. (2008), Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer. Archives of Surgery. 143(4), 389-394. [Abstract]
  • Lee, B., King, M., Simpson, J., Haran, M., Stockler, M., Marial, O., Salkeld, G. (2008), Validity, Responsiveness, and Minimal Important Difference for the SF-6D Health Utility Scale in a Spinal Cord Injured Population. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(0), 680-8. [Abstract]
  • Entwistle, V., Carter, S., Trevena, L., Flitcroft, K., Irwig, L., McCaffery, K., Salkeld, G. (2008), Communicating about screening. BMJ. 337(0), a1591. [Abstract]